Publicaciones Científicas

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia

S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,V. Idrovo,J. P. Ortiz,M. Tapias,J. Obregon,J. G. Ariza and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Colombia Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina

S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,F. Bessone,H. Fainboim,A. Gadano,O. Galdame,C. Vujacich and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Argentina Ver más »

Cost-Effectiveness Analysis Of A Randomized Trial Of An Mhealth Intervention To Improve Cardiometabolic Profile In Prehypertensive Subjects From Low-Resource Urban Settings In Latin America

R. Augustovski,A. Palacios,A. Beratarrechea,F. Diez-Canseco,V. Irazola,M. Ramirez-Zea,A. Pichon-Riyiere and A. Rubinstein. COST-EFFECTIVENESS ANALYSIS OF A RANDOMIZED TRIAL OF AN MHEALTH INTERVENTION TO IMPROVE CARDIOMETABOLIC PROFILE IN PREHYPERTENSIVE SUBJECTS FROM LOW-RESOURCE URBAN SETTINGS IN LATIN AMERICA. Value in Health. 2017;20(9).

Cost-Effectiveness Analysis Of A Randomized Trial Of An Mhealth Intervention To Improve Cardiometabolic Profile In Prehypertensive Subjects From Low-Resource Urban Settings In Latin America Ver más »

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

L. Schluckebier,R. Caetano,O. U. Garay,G. T. Montenegro,M. Custodio,V. Aran and C. Gil Ferreira. Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients. BMC Cancer. 2020;20(1):10.1186/s12885-020-07240-2.

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients Ver más »

COST ESTIMATION OF THE CHRONIC HEMODIALYSIS AND HEMODIALFILTRATION SERVICES IN ARGENTINA

A. Palacios,C. Mengarelli and F. Augustovski. COST ESTIMATION OF THE CHRONIC HEMODIALYSIS AND HEMODIALFILTRATION SERVICES IN ARGENTINA. Value in Health. 2017;20(9):10.1016/j.jval.2017.08.2523.

COST ESTIMATION OF THE CHRONIC HEMODIALYSIS AND HEMODIALFILTRATION SERVICES IN ARGENTINA Ver más »

Correction: Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis

R. I. Zahroh,A. Hazfiarini,K. E. Eddy,J. P. Vogel,Ӧ. Tunçalp,N. Minckas,F. Althabe,O. T. Oladapo and M. A. Bohren. Correction: Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis. PLoS Med. 2022;19(9):10.1371/journal.pmed.1004105.

Correction: Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis Ver más »

Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

D. Husereau,M. Drummond,F. Augustovski,E. de Bekker-Grob,A. H. Briggs,C. Carswell,L. Caulley,N. Chaiyakunapruk,D. Greenberg,E. Loder,J. Mauskopf,C. D. Mullins,S. Petrou,R. F. Pwu and S. Staniszewska. Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. Appl Health Econ Health Policy. 2022;20(5):10.1007/s40258-022-00743-y.

Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations Ver más »

Correction to: Toda mujer en el mundo debe tener un cuidado respetuoso durante el parto: una reflexión

J. M. Belizán,S. Miller,C. Williams and V. Pingray. Correction to: Toda mujer en el mundo debe tener un cuidado respetuoso durante el parto: una reflexión. Reprod Health. 2020;17(1):10.1186/s12978-020-00950-7.

Correction to: Toda mujer en el mundo debe tener un cuidado respetuoso durante el parto: una reflexión Ver más »

Coproduction of healthcare services—from concept to implementation

P. Batalden,P. Lachman,C. von Plessen,J. K. Johnson and E. García-Elorrio. Coproduction of healthcare services—from concept to implementation. International Journal for Quality in Health Care. 2023;35(4):10.1093/intqhc/mzad083.

Coproduction of healthcare services—from concept to implementation Ver más »

Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants

A. Rubinsteinand N. R. F. C. (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;47(3):10.1093/ije/dyy016.

Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants Ver más »